Literature DB >> 28901566

A new horizon in the prevention of the postembolization syndrome after transcatheter arterial chemoembolization for hepatocellular carcinoma.

Fabio Piscaglia1, Francesco Tovoli1, Patrizia Pini1, Veronica Salvatore1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28901566     DOI: 10.1002/hep.29517

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

Review 1.  Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment.

Authors:  Fabio Piscaglia; Sadahisa Ogasawara
Journal:  Liver Cancer       Date:  2018-01-12       Impact factor: 11.740

Review 2.  Pancreas lipiodol embolism induced acute necrotizing pancreatitis following transcatheter arterial chemoembolization for hepatocellular carcinoma: A case report and literature review.

Authors:  Youwen Tan; Jianhui Sheng; Huiying Tan; Jianzhong Mao
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

3.  Identifying predictors and evaluating the role of steroids in the prevention of post-embolization syndrome after transarterial chemoembolization and bland embolization.

Authors:  Rohit Agrawal; Muhammad Majeed; Sheeba-Ba Aqeel; Yuchen Wang; Zohaib Haque; Yazan Abu Omar; Shristi Banskota Upadhyay; Thomas Gast; Bashar M Attar; Seema Gandhi
Journal:  Ann Gastroenterol       Date:  2020-12-12

4.  Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival-prospective interventional study.

Authors:  Ahmed A Bessar; Ahmed Farag; Sameh M Abdel Monem; Fady M Wadea; Shady E Shaker; Mahmoud Ahmed Ebada; Manar A Bessar
Journal:  Eur Radiol Exp       Date:  2021-03-02

5.  Determination of risk factors for fever after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.

Authors:  Jinpeng Li; Congcong Shi; Jutian Shi; Jinlong Song; Nan Wang
Journal:  Medicine (Baltimore)       Date:  2021-11-05       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.